Your browser doesn't support javascript.
Caution should be exercised when assessing ivermectin for the treatment of COVID-19 in systematic reviews.
Deng, Jiawen; Zhou, Fangwen; Heybati, Kiyan; Kavanagh, Kyra.
  • Deng J; Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
  • Zhou F; Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
  • Heybati K; Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Kavanagh K; Faculty of Science, Carleton University, Ottawa, Ontario, Canada.
Rev Med Virol ; 32(5): e2317, 2022 09.
Article in English | MEDLINE | ID: covidwho-1565230
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Reviews / Systematic review/Meta Analysis Limits: Humans Language: English Journal: Rev Med Virol Journal subject: Virology Year: 2022 Document Type: Article Affiliation country: Rmv.2317

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Reviews / Systematic review/Meta Analysis Limits: Humans Language: English Journal: Rev Med Virol Journal subject: Virology Year: 2022 Document Type: Article Affiliation country: Rmv.2317